Short Interest in BlackRock Health Sciences Trust (NYSE:BME) Decreases By 49.2%

BlackRock Health Sciences Trust (NYSE:BMEGet Free Report) was the target of a significant decline in short interest during the month of January. As of January 31st, there was short interest totalling 29,900 shares, a decline of 49.2% from the January 15th total of 58,900 shares. Based on an average daily trading volume, of 43,000 shares, the short-interest ratio is currently 0.7 days.

Hedge Funds Weigh In On BlackRock Health Sciences Trust

A number of institutional investors have recently added to or reduced their stakes in the company. AdvisorNet Financial Inc acquired a new position in shares of BlackRock Health Sciences Trust in the third quarter valued at $31,000. Stonebridge Capital Advisors LLC bought a new position in shares of BlackRock Health Sciences Trust in the third quarter valued at about $31,000. Nemes Rush Group LLC bought a new position in shares of BlackRock Health Sciences Trust in the second quarter valued at about $37,000. Farmers & Merchants Investments Inc. bought a new position in shares of BlackRock Health Sciences Trust in the fourth quarter valued at about $40,000. Finally, Pathstone Family Office LLC bought a new position in shares of BlackRock Health Sciences Trust in the fourth quarter valued at about $252,000.

BlackRock Health Sciences Trust Stock Performance

Shares of BME opened at $42.65 on Tuesday. BlackRock Health Sciences Trust has a 1-year low of $35.53 and a 1-year high of $43.50. The company’s fifty day simple moving average is $40.87 and its 200 day simple moving average is $39.48.

BlackRock Health Sciences Trust Announces Dividend

The company also recently announced a monthly dividend, which will be paid on Thursday, February 29th. Investors of record on Thursday, February 15th will be issued a dividend of $0.213 per share. The ex-dividend date of this dividend is Wednesday, February 14th. This represents a $2.56 dividend on an annualized basis and a yield of 5.99%.

About BlackRock Health Sciences Trust

(Get Free Report)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.

Featured Articles

Receive News & Ratings for BlackRock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.